MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-12-2026
AVITA Medical General and Administrative Expenses 2011-2026 | RCEL
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses AVITA Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27.4 M | 33.2 M | 28.3 M | 23.3 M | 11 M | 34.6 M | 12.7 M | 5.29 M | 9.29 M | 5.58 M | 3.41 M | 5.48 M | 5.05 M | 5.65 M | 5.25 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 34.6 M | 3.41 M | 14.4 M |
Quarterly General and Administrative Expenses AVITA Medical
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.23 M | 6.39 M | - | 9.59 M | 7.52 M | 8.96 M | - | 6.12 M | 6.16 M | 8.3 M | - | 5 M | 5.47 M | 7.53 M | - | 5.35 M | 5.28 M | 5.42 M | 3.4 M | 8.3 M | 3.4 M | 5.54 M | 7.11 M | 3.42 M | 3.93 M | 3.65 M | 3.4 M | 2.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 9.59 M | 2.6 M | 5.79 M |
General and Administrative Expenses of other stocks in the Medical devices industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
1.76 B | $ 187.6 | 3.83 % | $ 14 B |  USA |
 |
Avinger
AVGR
|
14.1 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.2 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
15.1 M | - | 1.37 % | $ 20.5 M | USA |
 |
AxoGen
AXGN
|
44.6 M | $ 34.53 | 3.15 % | $ 1.59 B | USA |
 |
BioSig Technologies
BSGM
|
67.5 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
28.8 M | - | - | $ 16.4 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
25.6 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
14.1 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
382 M | $ 12.79 | 3.77 % | $ 1.73 B | USA |
 |
Allied Healthcare Products
AHPI
|
7.11 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
8.78 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
814 M | $ 292.96 | 1.66 % | $ 8.27 B | USA |
 |
Cytosorbents Corporation
CTSO
|
35.6 M | $ 0.58 | -0.87 % | $ 36.1 M | USA |
 |
IRIDEX Corporation
IRIX
|
7.73 M | $ 1.03 | - | $ 17.4 M | USA |
 |
EDAP TMS S.A.
EDAP
|
5.9 M | $ 3.31 | -0.6 % | $ 124 M |  France |
 |
Bruker Corporation
BRKR
|
894 M | $ 40.49 | 3.7 % | $ 6.03 K | USA |
 |
Boston Scientific Corporation
BSX
|
6.89 B | $ 64.37 | 1.88 % | $ 95.3 B | USA |
 |
Apollo Endosurgery
APEN
|
20.6 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
171 M | - | 0.15 % | $ 844 M | USA |
 |
LENSAR
LNSR
|
45.2 M | $ 6.04 | 1.94 % | $ 72.2 M | USA |
 |
ClearPoint Neuro
CLPT
|
16.5 M | $ 10.32 | 3.05 % | $ 292 M | USA |
 |
Dynatronics Corporation
DYNT
|
8.46 M | - | 14.99 % | $ 929 K | USA |
 |
Second Sight Medical Products
EYES
|
1.11 M | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
39.3 M | $ 25.25 | 1.2 % | $ 213 M | USA |
 |
Myomo
MYO
|
14 M | $ 0.76 | 3.59 % | $ 31.8 M | USA |
 |
Inogen
INGN
|
67.4 M | $ 6.45 | - | $ 172 M | USA |
 |
CryoLife, Inc.
CRY
|
141 M | - | -4.14 % | $ 702 M | USA |
 |
Soliton, Inc.
SOLY
|
8.46 M | - | -1.42 % | $ 435 M | USA |
 |
Sintx Technologies
SINT
|
6.2 M | $ 2.9 | -1.36 % | $ 8.04 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.88 K | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
8.88 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
8.5 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
18 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14.7 M | - | - | $ 111 M |  Canada |
 |
Globus Medical
GMED
|
1.18 B | $ 95.71 | 2.94 % | $ 12.9 B | USA |
 |
Stryker Corporation
SYK
|
8.65 B | $ 350.29 | 0.88 % | $ 134 B | USA |
 |
Tactile Systems Technology
TCMD
|
88.7 M | $ 24.76 | 2.15 % | $ 566 M | USA |
 |
Helius Medical Technologies
HSDT
|
9.27 M | $ 2.0 | -1.71 % | $ 1.22 M | USA |
 |
Butterfly Network
BFLY
|
39.8 M | $ 4.45 | 3.97 % | $ 942 M | USA |
 |
Intersect ENT, Inc.
XENT
|
98.6 M | - | - | $ 955 M | USA |
 |
TransMedics Group
TMDX
|
185 M | $ 116.71 | 2.96 % | $ 3.97 B | USA |
 |
Tandem Diabetes Care
TNDM
|
445 M | $ 20.61 | 2.54 % | $ 1.4 B | USA |
 |
BIOLASE
BIOL
|
10.2 M | - | -13.19 % | $ 166 K | USA |
 |
OrthoPediatrics Corp.
KIDS
|
120 M | $ 17.68 | 4.31 % | $ 415 M | USA |
 |
Delcath Systems
DCTH
|
43.5 M | $ 10.79 | 3.25 % | $ 387 M | USA |
 |
Inspire Medical Systems
INSP
|
625 M | $ 56.09 | 2.13 % | $ 1.65 B | USA |
 |
CONMED Corporation
CNMD
|
132 M | $ 39.52 | 2.76 % | $ 1.23 B | USA |